Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00932516 · ClinicalTrials.gov registry record · NA

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women

A NA study of Overweight, sponsored by Mondelēz International.

Completed
Registry status
NA
Development phase
248
Enrollment target
4
Study locations

NCT00932516: Completed NA study of Overweight, sponsored by Mondelēz International.

NCT00932516 is a NA study of Overweight that has completed, run by Mondelēz International. The registered enrollment target is 248 participants, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (81% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00932516, a NA study of Overweight, has completed, sponsored by Mondelēz International.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to examine the effectiveness of the South Beach Diet™ and South Beach Diet™ products compared to a traditional calorie restricted diet.

Conditions Studied

Interventions

  • BEHAVIORAL South Beach Diet™ with South Beach Diet™ Products
  • BEHAVIORAL South Beach Diet™
  • BEHAVIORAL Calorie restricted diet with South Beach Diet™ Products
  • BEHAVIORAL Calorie Restricted Diet

Study Locations (4)

Florida

  • SIBR Research - Bradenton
  • Miami Research Associates - Miami

California

  • Medicus Research - Northridge

Virginia

  • Chase Wellness & Research Center - Virginia Beach

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2007-03
Est. Completion 2008-04
Phase NA
Mondelēz International

7 total trials

What the finished NCT00932516 record still lists

NCT00932516 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 4 interventions - of which South Beach Diet™ with South Beach Diet™ Products is the first listed.

NCT00932516 reports a single indexed study location in Florida, California, Virginia.

Frequently Asked Questions

What is clinical trial NCT00932516 about?

NCT00932516 is a clinical study titled "Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women". The purpose of this study is to examine the effectiveness of the South Beach Diet™ and South Beach Diet™ products compared to a traditional calorie restricted diet.

What is the current status of trial NCT00932516?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2007-03. Estimated completion is 2008-04.

What conditions does trial NCT00932516 study?

This clinical trial studies the following conditions: Overweight.

What interventions are being tested in trial NCT00932516?

The interventions under investigation include: South Beach Diet™ with South Beach Diet™ Products (BEHAVIORAL), South Beach Diet™ (BEHAVIORAL), Calorie restricted diet with South Beach Diet™ Products (BEHAVIORAL), Calorie Restricted Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT00932516?

This trial is sponsored by Mondelēz International, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00932516 being conducted?

This trial has 4 study locations across California, Florida, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00932516's enrollment target sits among peer trials

248 64th of 197 higher than 133 of 197 other Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04577911 · 248 participants

    How is Social Connection Represented in the Brain?

  • NCT04777994 · 248 participants · Phase 1

    Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • NCT04792489 · 248 participants · Phase 2

    DALY II USA/ MB-CART2019.1 for DLBCL

  • NCT04830137 · 248 participants · Phase 1

    A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00932516, the US trial registry maintained by the National Library of Medicine. NCT00932516 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.